apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Zita Plus -Pio Tablet

  3. Zita Plus -Pio Tablet Substitute

Zita Plus -Pio Tablet Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

PIOGLITAZONE-15MG + TENELIGLIPTIN-20MG

Uses:

Zita Plus -Pio Tablet is used in the treatment of type-2 diabetes mellitus. The detailed uses of Zita Plus -Pio Tablet are as follows:<br/>• Manage type 2 diabetes mellitus: Zita Plus -Pio Tablet is used to manage type 2 diabetes mellitus in adults.<br/>• Sensitivity to insulin: Zita Plus -Pio Tablet improves the body's sensitivity to insulin, helping cells absorb glucose more effectively.<br/>

Medicinal Benefits:

Zita Plus -Pio Tablet contains Pioglitazone (thiazolidinediones) and Teneligliptin (dipeptidyl peptidase 4 inhibitors). It is used to treat type-2 diabetes mellitus. Pioglitazone lowers blood sugar levels by restoring the proper insulin amount in the body. Teneligliptin decreases the release of glucagon, a hormone that raises blood sugar levels, and increases the release of insulin from the pancreas. Together, Zita Plus -Pio Tablet helps treat type-2 diabetes mellitus.

FAQs

Zita Plus -Pio Tablet is used to treat type-2 diabetes mellitus.

Zita Plus -Pio Tablet works by increasing the body's sensitivity to insulin and facilitates insulin release from the pancreas. Thereby, Zita Plus -Pio Tablet helps treat type-2 diabetes mellitus.

Do not stop taking Zita Plus -Pio Tablet without consulting the doctor, as it may increase blood glucose levels. To treat your condition effectively, continue taking Zita Plus -Pio Tablet for as long as your doctor has prescribed it. Do not hesitate to speak with your doctor if you experience difficulty taking Zita Plus -Pio Tablet .

In some cases, you may experience hypoglycaemia. Regularly monitor your blood sugar levels while taking Zita Plus -Pio Tablet . Consume sugary food or juice if you experience symptoms of hypoglycaemia, such as headache, dizziness, drowsiness, shakiness, faintness, confusion, and visual disturbances.